NEWS

Oneness Biotech Co., Ltd. receives a Hong Kong patent titled "TOPICAL FORMULATION FOR PROMOTING WOUND HEALING" on Fespixon cream (Research code: ON101).

2023-11-10
No 1 Date of announcement 2023/11/10 Time of announcement 17:20:22
Subject

Oneness Biotech Co., Ltd. receives a Hong Kong patent titled "TOPICAL FORMULATION FOR PROMOTING WOUND HEALING" on Fespixon cream (Research code: ON101).

To which item it meets paragraph 53 Date of events 2023/11/10
Statement
1.Date of occurrence of the event:2023/11/10
2.Company name:ONENESS BIOTECH CO., LTD.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):head office
4.Reciprocal shareholding ratios:NA
5.Cause of occurrence:The Company has been informed by the patent agency that
a Hong Kong patent titled ”TOPICAL FORMULATION FOR PROMOTING WOUND HEALING”
has been granted on the new drug Fespixon cream (Research code: ON101) under the patent number HK40003500.
6.Countermeasures:None
7.Any other matters that need to be specified(the information disclosure also meets the requirements of Article 7, subparagraph 9 of the Securities and Exchange Act Enforcement Rules, which brings forth a significant impact on shareholders rights or the price of the securities on public companies.):
(1)The new drug, Fespixon cream has been granted many international patents.
   The development of new drugs is lengthy so many new drugs are faced with
   expiring patent protection shortly after their market approval, which
   results in loss of market exclusivity. The Company has filed a new
   patent for the topical formulation of Fespixon cream with innovative and
   efficacious scientific data and has been granted such patent in Taiwan,
   the U.S., Europe, etc.
(2)The patent of the topical formulation of Fespixon new drug has been
   filed in major countries or regions of the global market. The granted
   patent term remains valid till 2037-2038. Extension of the patent term
   can be applied for up to 5 years after the product is approved to be
   marketed.
(3)During the term of the granted patent, Fespixon cream will be protected
   against any generic competition.
關閉

建議您使用以下瀏覽器觀看合一網站,
以獲得最佳瀏覽效果。

要下載瀏覽器,請直接點擊以下: IE瀏覽器現已不支援大多數網站,並將於2022年6月終止服務

如何使用IE找到Microsoft Edge?

  1. 開啟新分頁(紅色框)
    開啟新分頁
  2. 於搜尋框中打入Edge(紅色框),並按搜尋(藍色框)
    於搜尋框中打入Edge,並按搜尋
  3. 點擊【立即啟動】(藍框處)打開 Microsoft Edge
    啟動Microsoft Edge